Viewing Study NCT00756912

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-05-24 @ 11:43 AM
Study NCT ID: NCT00756912
Status: TERMINATED
Last Update Posted: 2014-07-11
First Post: 2008-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors
Sponsor: Eisai Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ANC View
None BMT View
None graft versus leukemia View
None graft vs. host disease View
None MD2 (endotoxin binding-protein) View
None undergo allogeneic BMT View
None myeloablative View
None conditioning View
None therapy View